Condition: Arthritis, Juvenile Idiopathic
Interventions: Biological: Double-Blind Adalimumab/Placebo + MTX; Biological: Double-Blind Adalimumab/Placebo; Drug: OLE BSA Adalimumab +/- MTX; Drug: OLE FD Adalimumab +/- MTX
Sponsor: Abbott
Completed - verified August 2011
